Cancer
Showing NaN - NaN of 50
Validation of the European Oncology Quality of Life Toolkit
Not yet recruiting
- Cancer
- +2 more
- Administration of the EUonQoL-Kit - Active Treatment questionnaire
- +2 more
-
Tirana, Albania
- +44 more
Jul 17, 2023
Cancer Trial in Barcelona (MBF-018 oral capsules, Placebo oral capsule)
Active, not recruiting
- Cancer
- MBF-018 oral capsules
- Placebo oral capsule
-
Barcelona, SpainCIM-Sant Pau Institut de Recerca de l'Hospital de la Santa Creu
Jun 28, 2023
Cancer, NSCLC (NSCLC) Trial in Worldwide (Cofetuzumab Pelidotin)
Recruiting
- Cancer
- Non-small Cell Lung Cancer (NSCLC)
- Cofetuzumab Pelidotin
-
Birmingham, Alabama
- +25 more
Jan 31, 2023
Cancer, Cancer, Lung, Cancer of Lung Trial in Worldwide (UV1 vaccine + leukine, ipilimumab, nivolumab)
Active, not recruiting
- Cancer
- +6 more
- UV1 vaccine + leukine
- +2 more
-
Perth, Australia
- +6 more
Jan 23, 2023
Solid Tumors, Cancer Trial in Worldwide (MEDI1191, Durvalumab)
Active, not recruiting
- Solid Tumors
- Cancer
- MEDI1191
- Durvalumab
-
La Jolla, California
- +13 more
Nov 30, 2022
NSCLC, Anemia, Cancer Trial in Worldwide (Darbepoetin alfa, Placebo)
Terminated
- Non-Small Cell Lung Cancer
- +3 more
- Darbepoetin alfa
- Placebo
-
Anniston, Alabama
- +566 more
Nov 4, 2022
Pro-Vegetarian Diets, Microbial/Metabolite Profiles and Cancer
Recruiting
- Dietary Habits
- +4 more
- This is an observational study
-
Barcelona, Spain
- +5 more
Nov 20, 2022
Cancer Trial in Spain, United Kingdom (RP2, nivolumab)
Recruiting
- Cancer
- RP2
- nivolumab
-
Barcelona, Spain
- +5 more
Nov 11, 2022
Acute Myeloid Leukemia (AML), Cancer Trial in Worldwide (Venetoclax, Azacitidine, Best Supportive Care (BSC))
Recruiting
- Acute Myeloid Leukemia (AML)
- Cancer
- Venetoclax
- +2 more
-
Scottsdale, Arizona
- +169 more
Aug 23, 2022
Breast Cancer, Cancer Trial in Worldwide (Nivolumab, Anastrozole, Palbociclib)
Completed
- Breast Cancer
- Cancer
- Nivolumab
- +2 more
-
Whittier, California
- +35 more
Jul 14, 2022
Cancer Trial in Worldwide (Darolutamide (Nubeqa, BAY1841788))
Recruiting
- Cancer
- Darolutamide (Nubeqa, BAY1841788)
-
Homewood, Alabama
- +335 more
Aug 8, 2022
Patients With Atrial Fibrillation and Cancer
Active, not recruiting
- Atrial Fibrillation
- Cancer
-
Aalst, Belgium
- +118 more
Mar 15, 2022
Renal Cell Carcinoma (RCC), Cancer Trial in Worldwide (pazopanib, )
Completed
- Renal Cell Carcinoma (RCC)
- Cancer
- pazopanib
- placebo
-
Jonesboro, Arkansas
- +311 more
Oct 29, 2020
Cancer, Breast Cancer Trial in Worldwide (Ixabepilone + Capecitabine, Capecitabine)
Completed
- Cancer
- Breast Cancer
- Ixabepilone + Capecitabine
- Capecitabine
-
Tucson, Arizona
- +188 more
Oct 6, 2020